Bioatla logo

Bioatla share price today

(BCAB)

Bioatla share price is $0.62 & ₹52.82 as on 25 Dec 2024, 2.30 'hrs' IST

$0.62

0.01

(1.57%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Bioatla share price in Dollar and Rupees. Guide to invest in Bioatla from India. Also see the sentimental analysis on Indian investors investing in Bioatla. Get details on the Indian mutual funds that are investing in Bioatla. Get Analyst recommendations and forecasts along with all the Bioatla's financials.

Bioatla share price movements

  • Today's Low: $0.57
    Today's High: $0.64

    Day's Volatility :11.15%

  • 52 Weeks Low: $0.57
    52 Weeks High: $4.02

    52 Weeks Volatility :85.82%

Bioatla Returns

PeriodBioatla IncSector (Health Care)Index (Russel 2000)
3 Months
-61.93%
-8.7%
0.0%
6 Months
-57.78%
-5.0%
0.0%
1 Year
-80.48%
3.2%
0.0%
3 Years
-96.78%
0.0%
-21.1%

Bioatla Key Statistics

in dollars & INR

Previous Close
$0.611
Open
$0.6348
Today's High
$0.644
Today's Low
$0.5722
Market Capitalization
$29.5M
Today's Volume
$1.8M
52 Week High
$4.02
52 Week Low
$0.57
Revenue TTM
$11.0M
EBITDA
$-85.2M
Earnings Per Share (EPS)
$-1.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-139.06%

How to invest in Bioatla from India?

It is very easy for Indian residents to invest directly in Bioatla from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioatla stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioatla or BCAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioatla or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioatla shares which would translate to 1.374 fractional shares of Bioatla as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bioatla, in just a few clicks!

Returns in Bioatla for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioatla investment value today

Current value as on today

₹21,923

Returns

₹78,077

(-78.08%)

Returns from Bioatla Stock

₹80,503 (-80.5%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Bioatla

58%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Bioatla on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 58% more investors are searching Bioatla in the last 30 days versus the previous period.

Global Institutional Holdings in Bioatla

  • Millennium Management LLC

    5.50%

  • Soleus Capital Management, L.P.

    5.21%

  • Vanguard Group Inc

    3.90%

  • Morgan Stanley - Brokerage Accounts

    3.84%

  • TANG CAPITAL MANAGEMENT LLC

    1.81%

  • BlackRock Inc

    1.64%

Analyst Recommendation on Bioatla

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Bioatla(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Bioatla

What analysts predicted

Upside of 1351.61%

Current:

$0.62

Target:

$9.00

Insights on Bioatla

  • Price Movement

    In the last 7 days, BCAB stock has moved down by -47.4%
  • BCAB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 99.5%
  • BCAB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 122.1%
  • Price to Sales

    ForBCAB every $1 of sales, investors are willing to pay $2.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Bioatla Technicals Summary

Sell

Neutral

Buy

Bioatla is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bioatla Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioatla Inc
-62.61%
-57.78%
-80.48%
-96.78%
-98.0%
Regeneron Pharmaceuticals, Inc.
-4.68%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-5.49%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.08%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-11.59%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioatla Inc
NA
NA
NA
-1.52
-1.39
-0.5
NA
0.48
Regeneron Pharmaceuticals, Inc.
17.7
17.7
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioatla Inc
Buy
$29.5M
-98.0%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.6B
91.19%
17.7
33.61%
Biontech Se
Buy
$27.2B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.2B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$104.4B
86.41%
32.84
-4.51%

About Bioatla

bioatla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. the culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our conditionally active biologics (cab) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. this improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. bioatla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.
Organization
Bioatla
Employees
65
CEO
Dr. Jay M. Short Ph.D.
Industry
Healthcare

Management People of Bioatla

NameTitle
Dr. Jay M. Short Ph.D.
Co-Founder, CEO & Chairman
Mr. Richard A. Waldron
Senior VP & CFO
Dr. Eric L. Sievers M.D.
Chief Medical Officer
Mr. Christian J. Vasquez CPA
Chief Accounting Officer, Controller and Corporate Secretary
Ms. Susie Melody
Senior Vice President of Human Resources
Dr. Cathy Chang Ph.D.
Senior Vice President of Research & Development
Dr. Gerhard Frey Ph.D.
Senior Vice President of Technology Development
Ms. Monica Sullivan
Senior Vice President of Intellectual Property & Contracts
Ms. Sheri Lydick
Chief Commercial Officer
Lisa M. Pelton
Accounting Manager

Important FAQs about investing in Bioatla from India :

What is Bioatla share price today?

Bioatla share price today stands at $0.62, Open: $0.63 ; Previous Close: $0.61 ; High: $0.64 ; Low: $0.57 ; 52 Week High: $4.02 ; 52 Week Low: $0.57. The stock opens at $0.63, after a previous close of $0.61. The stock reached a daily high of $0.64 and a low of $0.57, with a 52-week high of $4.02 and a 52-week low of $0.57.

Can Indians buy Bioatla shares?

Yes, Indians can invest in the Bioatla (BCAB) from India.

With INDmoney, you can buy Bioatla at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioatla at zero transaction cost.

How can I buy Bioatla shares from India?

It is very easy to buy Bioatla from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioatla be purchased?

Yes, you can buy fractional shares of Bioatla with INDmoney app.

What are the documents required to start investing in Bioatla stocks?

To start investing in Bioatla, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioatla

Today’s highest price of Bioatla (BCAB) is $0.64.

Today’s lowest price of Bioatla (BCAB) is $0.57.

What is today's market capitalisation of Bioatla

Today's market capitalisation of Bioatla BCAB is 29.5M

What is the 52 Week High and Low Range of Bioatla

  • 52 Week High

    $4.02

  • 52 Week Low

    $0.57

What are the historical returns of Bioatla?

  • 1 Month Returns

    -62.61%

  • 3 Months Returns

    -57.78%

  • 1 Year Returns

    -80.48%

  • 5 Years Returns

    -98%

Who is the Chief Executive Officer (CEO) of Bioatla

Dr. Jay M. Short Ph.D. is the current Chief Executive Officer (CEO) of Bioatla.